NutriStack
NAC and Risperidone, a synergy.
NAC has human trial evidence as an adjunct to risperidone for negative symptoms of schizophrenia. The effect is not immediate and does not replace antipsychotic treatment, but it may modestly improve residual symptoms in some patients. Evidence is strongest for adjunctive use over weeks to months rather than as-needed dosing.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Substances
- NAC and Risperidone
- Pair type
- Synergy
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- +2 to your Stack Score (per scored synergy row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Synergy · Moderate evidence
Synergy
What is happening. NAC has human trial evidence as an adjunct to risperidone for negative symptoms of schizophrenia. The effect is not immediate and does not replace antipsychotic treatment, but it may modestly improve residual symptoms in some patients. Evidence is strongest for adjunctive use over weeks to months rather than as-needed dosing.
Mechanism. NAC replenishes cysteine for glutathione synthesis and modulates glutamatergic signaling through the cystine-glutamate antiporter. These effects may complement risperidone's D2 and 5-HT2A receptor antagonism by targeting oxidative stress and glutamate dysregulation linked to negative symptoms.
Recommendation. Do not use NAC as a substitute for risperidone. If you add NAC, keep risperidone unchanged unless your prescriber changes it, and track symptoms over several weeks. Stop and ask for guidance if NAC causes persistent stomach upset, wheezing, rash, or medication-adherence confusion.
Sources (2)
- Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani MR, Hosseini SM, Yekehtaz H, et al. N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study. Clin Neuropharmacol. 2013;36(6):185-192. PMID 24201233
- Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, et al. Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs. BMJ Ment Health. 2023;26(1):e300771. PMID 37852631
Stack Score
How this pair moves the number.
Effect on the composite score
If both NAC and Risperidone are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.